Gemcitabine with nab-paclitaxel in patients with locally advanced or metastatic pancreatic ductal adenocarcinoma (PDAC): A quality of life randomized cross-over study (QOLINPAC)
- Resource Type
- Source
- Annals of Oncology. 29:v101
- Subject
0301 basic medicine Oncology medicine.medical_specialty Pancreatic ductal adenocarcinoma business.industry Locally advanced Hematology Crossover study Gemcitabine 03 medical and health sciences 030104 developmental biology 0302 clinical medicine Quality of life 030220 oncology & carcinogenesis Internal medicine medicine In patient business medicine.drug Nab-paclitaxel - Language
- ISSN
- 0923-7534